au.\*:("THAM, Lai-San")
Results 1 to 5 of 5
Selection :
A warfarin-dosing model in Asians that uses single-nucleotide polymorphisms in vitamin K epoxide reductase complex and cytochrome P450 2C9THAM, Lai-San; GOH, Boon-Cher; NAFZIGER, Anne et al.Clinical pharmacology and therapeutics. 2006, Vol 80, Num 4, pp 346-355, issn 0009-9236, 10 p.Article
A Pharmacodynamic Model for the Time Course of Tumor Shrinkage by Gemcitabine + Carboplatin in Non-Small Cell Lung Cancer PatientsTHAM, Lai-San; LINGZHI WANG; SOO, Ross A et al.Clinical cancer research. 2008, Vol 14, Num 13, pp 4213-4218, issn 1078-0432, 6 p.Article
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancersYONG, Wei-Peng; WANG, Ling-Zhi; THAM, Lai-San et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 2, pp 243-251, issn 0344-5704, 9 p.Article
Does saturable formation of gemcitabine triphosphate occur in patients?THAM, Lai-San; WANG, Ling-Zhi; SOO, Ross A et al.Cancer chemotherapy and pharmacology. 2008, Vol 63, Num 1, pp 55-64, issn 0344-5704, 10 p.Article
Lack of Association of Single-Nucleotide Polymorphisms in Pregnane X Receptor, Hepatic Nuclear Factor 4α, and Constitutive Androstane Receptor with Docetaxel PharmacokineticsTHAM, Lai-San; HOLFORD, Nicholas H. G; HOR, Sok-Ying et al.Clinical cancer research. 2007, Vol 13, Num 23, pp 7126-7132, issn 1078-0432, 7 p.Article